av/astrazeneca--big.svg

NSE:ASTRAZEN

AstraZeneca Pharma India Limited

  • Stock

INR

Last Close

6,661.50

30/08 10:00

Market Cap

171.96B

Beta: 0.39

Volume Today

6.17K

Avg: 4.82K

PE Ratio

108.89

PFCF: 7,021.31

Dividend Yield

0.24%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
905.63M
-
909.44M
0.42%
814.30M
10.46%
672.24M
17.45%
854.34M
27.09%
1.16B
35.34%
1.42B
22.49%
1.62B
14.72%
1.50B
7.67%
1.65B
10.14%
average payables
1.00B
-
1.11B
10.27%
1.03B
6.89%
651.99M
36.67%
655.55M
0.55%
1.32B
101.01%
1.89B
43.40%
1.94B
2.69%
1.83B
5.58%
2.08B
13.51%
average receivables
743.08M
-
1.20B
61.38%
1.33B
10.96%
967.59M
27.28%
718.62M
25.73%
776.60M
8.07%
934.05M
20.27%
934.08M
0.00%
947.51M
1.44%
1.03B
8.65%
book value per share
68.64
-
60.30
12.14%
62.41
3.49%
72.18
15.67%
98.77
36.84%
120.32
21.82%
145.78
21.16%
182.47
25.17%
204.56
12.11%
235.49
15.12%
capex per share
-8.65
-
-9.52
10.04%
-3.62
62.00%
-2.25
37.70%
-2.51
11.44%
-7.48
197.61%
-5.69
23.92%
-3.08
45.78%
-3.85
24.77%
-3.41
11.43%
capex to depreciation
-2.14
-
-1.56
27.09%
-0.52
66.68%
-0.36
31.39%
-0.43
19.65%
-1.25
194.02%
-0.77
38.90%
-0.39
48.99%
-0.57
45.38%
-0.52
7.68%
capex to operating cash flow
26.79
-
0.52
98.06%
-0.16
130.47%
-0.15
7.31%
-0.71
385.67%
-0.34
52.42%
-0.16
52.15%
-0.07
54.76%
-0.10
29.70%
-0.15
53.13%
capex to revenue
-0.05
-
-0.05
11.14%
-0.02
66.15%
-0.01
39.21%
-0.01
5.30%
-0.03
133.35%
-0.02
33.39%
-0.01
44.22%
-0.01
25.23%
-0.01
28.86%
cash per share
35.07
-
9.58
72.70%
30.48
218.32%
45.82
50.32%
50.26
9.70%
69.30
37.86%
101
45.75%
143.20
41.78%
184.29
28.70%
204.44
10.93%
days of inventory on hand
194.01
-
154.90
20.16%
131.60
15.04%
104.37
20.69%
184.75
77.01%
159.87
13.46%
180.28
12.76%
176.46
2.12%
143.18
18.86%
151.69
5.95%
days payables outstanding
222.60
-
200.12
10.10%
162.30
18.90%
64.68
60.15%
155.67
140.66%
227.69
46.27%
228.93
0.54%
196.97
13.96%
192.03
2.51%
181.73
5.36%
days sales outstanding
67.50
-
118.46
75.49%
78.97
33.33%
53.86
31.80%
40.98
23.91%
45.72
11.55%
41.95
8.23%
41.18
1.85%
44.53
8.15%
39.16
12.06%
debt to assets
0.00
-
0.00
0.97%
0.02
-
0.02
6.51%
0.01
35.71%
0.01
27.30%
debt to equity
0.00
-
0.00
13.82%
0.03
-
0.03
18.08%
0.02
36.59%
0.01
27.39%
dividend yield
0.00
-
0.00
59.76%
0.00
17.93%
0.00
213.83%
earnings yield
-0.00
-
-0.01
4,812.87%
0.00
120.12%
0.01
473.85%
0.01
5.54%
0.01
1.84%
0.01
10.94%
0.01
3.21%
0.01
22.14%
0.01
26.46%
enterprise value
27.58B
-
23.01B
16.56%
28.81B
25.19%
23.37B
18.88%
22.34B
4.38%
48.54B
117.25%
59.38B
22.33%
71.83B
20.97%
59.40B
17.31%
76.38B
28.59%
enterprise value over ebitda
-94.77
-
-486.14
412.98%
172.52
135.49%
53.21
69.15%
44.08
17.17%
68.14
54.58%
44.51
34.67%
49.15
10.42%
60.36
22.80%
68.96
14.25%
ev to operating cash flow
-3.41K
-
-50.35
98.53%
50.55
200.39%
61.00
20.67%
254.20
316.72%
88.29
65.27%
67.92
23.07%
68.55
0.93%
58.93
14.04%
131.02
122.34%
ev to sales
5.82
-
4.91
15.72%
5.47
11.54%
4.33
20.85%
3.91
9.65%
6.67
70.34%
7.14
7.10%
8.88
24.44%
7.37
17.00%
7.62
3.29%
free cash flow per share
-8.98
-
-27.80
209.72%
19.18
168.98%
13.07
31.85%
1.00
92.32%
14.52
1,345.82%
29.28
101.71%
38.83
32.61%
36.47
6.07%
19.91
45.40%
free cash flow yield
-0.01
-
-0.03
271.59%
0.02
155.01%
0.01
15.86%
0.00
92.35%
0.01
575.37%
0.01
68.74%
0.01
5.93%
0.01
10.77%
0.01
57.17%
graham net net
-17.09
-
-31.87
86.44%
-19.89
37.60%
2.33
111.72%
6.68
186.70%
15.88
137.60%
25.94
63.37%
75.11
189.52%
103.75
38.14%
116.28
12.07%
graham number
17.73
-
106.35
499.80%
54.35
48.90%
126.01
131.86%
151.77
20.44%
242.82
60.00%
307.80
26.76%
391.43
27.17%
336.76
13.97%
458.76
36.23%
income quality
1.59
-
2.19
38.19%
9.89
350.88%
1.15
88.33%
0.20
82.61%
0.76
276.99%
0.77
1.38%
0.82
7.48%
1.21
47.23%
0.43
64.19%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0.01
Infinity%
interest coverage
100.72
-
115.95
15.13%
85.75
26.05%
149.26
74.06%
interest debt per share
0.11
-
0.11
0%
5.19
-
5.29
1.93%
3.83
27.59%
3.14
18.09%
inventory turnover
1.88
-
2.36
25.25%
2.77
17.70%
3.50
26.10%
1.98
43.51%
2.28
15.56%
2.02
11.32%
2.07
2.16%
2.55
23.25%
2.41
5.61%
invested capital
0.00
-
0.00
13.82%
0.03
-
0.03
18.08%
0.02
36.59%
0.01
27.39%
market cap
27.62B
-
23.02B
16.65%
28.87B
25.39%
23.38B
19.01%
23.48B
0.44%
50.27B
114.08%
60.10B
19.54%
75.23B
25.19%
63.80B
15.20%
81.31B
27.46%
net current asset value
286.44M
-
24.23M
91.54%
185.77M
666.69%
554.81M
198.65%
1.07B
93.42%
1.44B
33.93%
2.00B
39.44%
3.00B
49.81%
3.60B
20.08%
4.39B
21.86%
net debt to ebitda
0.15
-
0.25
62.50%
-0.37
251.07%
-0.03
91.93%
-2.25
7,400.72%
-2.43
8.15%
-0.54
77.91%
-2.33
333.36%
-4.47
91.97%
-4.45
0.38%
net income per share
-0.20
-
-8.34
3,994.91%
2.10
125.24%
9.78
364.77%
10.36
6.00%
21.78
110.15%
28.88
32.62%
37.32
29.21%
24.64
33.98%
39.72
61.20%
operating cash flow per share
-0.32
-
-18.28
5,558.68%
22.80
224.70%
15.32
32.78%
3.52
77.05%
21.99
525.48%
34.97
59.00%
41.91
19.86%
40.32
3.80%
23.32
42.16%
payables turnover
1.64
-
1.82
11.24%
2.25
23.30%
5.64
150.92%
2.34
58.45%
1.60
31.63%
1.59
0.54%
1.85
16.23%
1.90
2.57%
2.01
5.67%
receivables turnover
5.41
-
3.08
43.02%
4.62
50.00%
6.78
46.63%
8.91
31.42%
7.98
10.36%
8.70
8.97%
8.86
1.88%
8.20
7.53%
9.32
13.72%
research and ddevelopement to revenue
return on tangible assets
-0.00
-
-0.05
4,034.65%
0.01
125.60%
0.06
399.19%
0.06
13.05%
0.10
72.27%
0.10
5.48%
0.12
17.81%
0.07
40.29%
0.10
41.28%
revenue per share
189.50
-
187.62
0.99%
210.58
12.24%
215.83
2.49%
228.40
5.82%
291.30
27.54%
332.71
14.22%
323.42
2.79%
322.24
0.37%
401.22
24.51%
roe
-0.00
-
-0.14
4,560.97%
0.03
124.38%
0.14
301.82%
0.10
22.53%
0.18
72.51%
0.20
9.46%
0.20
3.22%
0.12
41.11%
0.17
40.02%
roic
-0.23
-
-0.00
98.22%
0.08
2,097.71%
0.08
1.90%
0.14
71.76%
0.19
33.47%
0.19
3.03%
0.11
40.81%
0.12
1.50%
sales general and administrative to revenue
0.04
-
0.04
3.75%
0.03
18.91%
0.03
0.02%
0.02
28.85%
0.03
48.80%
0.03
1.59%
0.03
1.97%
0.03
8.37%
0.03
2.87%
shareholders equity per share
68.64
-
60.30
12.14%
62.41
3.49%
72.18
15.67%
98.77
36.84%
120.32
21.82%
145.78
21.16%
182.47
25.17%
204.56
12.11%
235.49
15.12%
stock based compensation to revenue
0.00
-
0.00
13.39%
0.00
3.22%
0.00
35.94%
0.00
23.42%
0.00
4.66%
tangible asset value
1.72B
-
1.51B
12.14%
1.56B
3.49%
1.80B
15.67%
2.47B
36.84%
3.01B
21.82%
3.64B
21.16%
4.56B
25.17%
5.11B
12.11%
5.81B
13.62%
tangible book value per share
68.64
-
60.30
12.14%
62.41
3.49%
72.18
15.67%
98.77
36.84%
120.32
21.82%
145.78
21.16%
182.47
25.17%
204.56
12.11%
235.49
15.12%
working capital
291.33M
-
34.42M
88.19%
198.44M
476.54%
679.01M
242.17%
1.14B
67.85%
1.46B
27.88%
2.15B
47.58%
3.15B
46.58%
3.73B
18.32%
4.52B
21.05%

All numbers in INR (except ratios and percentages)